Policy on Optimal Epilepsy Management
NCT01762215 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2013-01-07
Summary
This study examines the use of an online social media platform (PatientsLikeMe) to assist Veterans with epilepsy. The hypothesis is that the online social media platform, PatientsLikeMe, will improve selected patient-reported outcomes on perceived self-management skills for patients who engage in the website functions.
Conditions
- Epilepsy
- Seizure Disorder
Interventions
- BEHAVIORAL
-
PatientsLikeMe.com
PatientsLikeMe (PLM, www.patientslikeme.com) is an established medical social networking website that encourages patients with chronic medical conditions to voluntarily share their story and seek support from a common community. Additionally, PatientsLikeMe is actively exploring opportunities to allow patients to report and track important medical data points with the hope that this will improve their longitudinal care. PatientsLikeMe has developed custom functionality for the epilepsy population including seizure tracking, peer support, and printable doctor visit support sheets.
Sponsors & Collaborators
-
San Francisco Veterans Affairs Medical Center
collaborator FED -
Veterans Administration Epilepsy Centers of Excellence (ECoE)
collaborator FED -
University of California, San Francisco
collaborator OTHER -
PatientsLikeMe
collaborator OTHER -
UCB Pharma
collaborator INDUSTRY -
Northern California Institute of Research and Education
lead OTHER
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2013-10-31
- Completion
- 2013-12-31
Countries
- United States
Study Locations
More Related Trials
-
Prevention of Post-traumatic Seizures With Levetiracetam
NCT00566046 ·Status: TERMINATED ·Phase: PHASE3
-
Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?
NCT03054285 ·Status: UNKNOWN ·Phase: PHASE4
-
Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures
NCT00152516 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy.
NCT00156689 ·Status: COMPLETED ·Phase: PHASE2
-
Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy
NCT00242606 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam to Prevent Post-Traumatic Epilepsy
NCT01463033 ·Status: COMPLETED ·Phase: PHASE2
-
Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression
NCT00621751 ·Status: COMPLETED ·Phase: NA
-
Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases
NCT00415376 ·Status: WITHDRAWN ·Phase: NA
-
Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy
NCT00175903 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy
NCT00150748 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam
NCT00761774 ·Status: COMPLETED ·Phase: PHASE3
-
Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS
NCT00152373 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam for Benign Rolandic Epilepsy
NCT00181116 ·Status: COMPLETED ·Phase: PHASE4
-
Generic Substitution of Original Levetiracetam in Thai Epilepsy Patients
NCT04132063 ·Status: COMPLETED
-
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
NCT01521130 ·Status: COMPLETED ·Phase: PHASE1
-
Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study
NCT00223223 ·Status: COMPLETED ·Phase: PHASE4
-
Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam
NCT00152503 ·Status: COMPLETED ·Phase: PHASE2
-
Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903).
NCT00291655 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus
NCT01150331 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures
NCT00615615 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive and Behavioral Effects of Lacosamide
NCT01175954 ·Status: COMPLETED ·Phase: PHASE4
-
Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy
NCT00175851 ·Status: WITHDRAWN ·Phase: PHASE3
-
Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy
NCT00160628 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures
NCT01229735 ·Status: COMPLETED ·Phase: PHASE4
-
Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia
NCT01318408 ·Status: COMPLETED ·Phase: PHASE4